Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
US animal health firm Zomedica Pharmaceuticals has achieved a number of milestones for its pet therapeutics pipeline in 2017.
Australian animal health company CannPal has seen its European business prospects boosted with the granting of a small and medium size enterprise status (SME) by the European Medicines Agency (EMA).
Slovenian animal health company Krka said it has obtained marketing authorization for several new products in the first nine months of fiscal 2017.
UK company ECO Animal Health has received marketing authorization for its lead product Aivlosin in Canada.
US aquaculture health and genetics company Benchmark said commercial scale trials have proved a success for its sea lice treatment Ectosan.
A study of Swedish gene therapy firm Panion's epilepsy drug candidate has shown positive initial results.
Zoetis has received two supplemental approvals from the US FDA.
UK firm ECO Animal Health has seen a strong 8% increase in revenues during the first half of its fiscal 2017.
Swedish firm Oasmia Pharmaceuticals is aiming to list its veterinary assets on the Nasdaq through its wholly-owned US subsidiary.
The US has seen the sale and distribution of antibiotics approved for use in food-producing animals in the country decrease by 10% from 2015 to 2016.
Norbrook Laboratories has found cat owners prefer the new liquid form of its feline medicine Thyronorm.
For the third year running the UK's second largest animal health company Norbrook Laboratories has produced strong revenue results.
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.